Ossiam Acquires 8,136 Shares of The Clorox Company (NYSE:CLX)

Ossiam raised its holdings in The Clorox Company (NYSE:CLX) by 26.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,001 shares of the company’s stock after buying an additional 8,136 shares during the period. Ossiam’s holdings in The Clorox were worth $7,055,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CLX. Geode Capital Management LLC lifted its position in shares of The Clorox by 1.6% during the second quarter. Geode Capital Management LLC now owns 2,443,678 shares of the company’s stock valued at $438,672,000 after purchasing an additional 39,577 shares in the last quarter. Bank of New York Mellon Corp grew its stake in The Clorox by 4.8% during the first quarter. Bank of New York Mellon Corp now owns 1,551,035 shares of the company’s stock valued at $299,164,000 after acquiring an additional 70,987 shares in the last quarter. FMR LLC lifted its position in The Clorox by 47.4% during the second quarter. FMR LLC now owns 1,419,712 shares of the company’s stock valued at $255,421,000 after purchasing an additional 456,269 shares during the last quarter. Champlain Investment Partners LLC lifted its position in The Clorox by 34.3% during the second quarter. Champlain Investment Partners LLC now owns 1,395,525 shares of the company’s stock valued at $251,069,000 after purchasing an additional 356,260 shares during the last quarter. Finally, Stifel Financial Corp lifted its position in The Clorox by 5.9% during the second quarter. Stifel Financial Corp now owns 1,200,944 shares of the company’s stock valued at $216,066,000 after purchasing an additional 67,190 shares during the last quarter. 77.77% of the stock is currently owned by hedge funds and other institutional investors.

CLX has been the subject of several research analyst reports. Citigroup dropped their target price on shares of The Clorox from $219.00 to $194.00 and set a “buy” rating for the company in a research report on Wednesday, August 4th. Royal Bank of Canada lowered their price objective on shares of The Clorox from $200.00 to $176.00 and set a “sector perform” rating for the company in a report on Wednesday, August 4th. UBS Group lowered their price objective on shares of The Clorox from $166.00 to $154.00 and set a “sell” rating for the company in a report on Wednesday, August 4th. They noted that the move was a valuation call. Credit Suisse Group lowered their price objective on shares of The Clorox from $175.00 to $160.00 and set a “neutral” rating for the company in a report on Wednesday, August 4th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of The Clorox from $192.00 to $153.00 and set a “hold” rating for the company in a report on Wednesday, August 4th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, The Clorox has a consensus rating of “Hold” and an average price target of $182.11.

The Clorox stock traded up $0.10 during mid-day trading on Thursday, reaching $160.83. 3,272 shares of the company traded hands, compared to its average volume of 1,513,702. The company has a debt-to-equity ratio of 4.20, a current ratio of 0.89 and a quick ratio of 0.52. The firm’s 50 day moving average price is $166.55 and its 200 day moving average price is $176.86. The firm has a market capitalization of $19.75 billion, a price-to-earnings ratio of 29.01, a P/E/G ratio of 4.37 and a beta of 0.21. The Clorox Company has a 52-week low of $159.32 and a 52-week high of $231.11.

The Clorox (NYSE:CLX) last issued its quarterly earnings data on Tuesday, August 3rd. The company reported $0.95 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.34). The company had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.91 billion. The Clorox had a net margin of 9.67% and a return on equity of 94.42%. The firm’s revenue for the quarter was down 9.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.41 earnings per share. On average, sell-side analysts anticipate that The Clorox Company will post 5.54 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 10th. Stockholders of record on Wednesday, October 27th will be given a $1.16 dividend. This represents a $4.64 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date of this dividend is Tuesday, October 26th. The Clorox’s dividend payout ratio is presently 64.00%.

The Clorox Company Profile

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Cleaning, Lifestyle, Household, and International. The Cleaning segment consists of laundry, home care, and professional products marketed and sold in the United States.

Featured Story: Dual Listing

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).

Institutional Ownership by Quarter for The Clorox (NYSE:CLX)

Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.